News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avigen, Inc. (AVGN) Stops Development of Lead Drug; Reduces Headcount by 70%


12/22/2008 7:57:17 AM

Dec 22 (Reuters) - Biopharmaceutical company Avigen Inc said it would stop all clinical trials of its experimental treatment for spasticity related to multiple sclerosis, which failed a mid-stage trial in October.

Read at Reuters
Read at MSN


comments powered by Disqus
Reuters
MSN
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES